122 results in Exploration of Digestive Diseases
Most Cited
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
The central role of mitochondrial metabolism in hepatic steatosis
Sanda Win ... Filbert Win Min Aung
Published: February 29, 2024 Explor Dig Dis. 2024;3:42–68
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Review
Impact of mitochondrial lipid alterations on liver disease mechanisms and progression
Laura Fàbrega ... Carmen Garcia-Ruiz
Published: September 10, 2024 Explor Dig Dis. 2024;3:382–413
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Review
Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases
Hala Saeed Jaara, Sandra Torres
Published: December 10, 2024 Explor Dig Dis. 2024;3:474–503
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Editorial
Extra-hepatic cancers in metabolic fatty liver syndromes
Amedeo Lonardo
Published: February 24, 2023 Explor Dig Dis. 2023;2:11–17
Open Access
Review
Extracellular vesicles in metabolic dysfunction associated fatty liver disease: mechanisms, diagnostic and therapeutic implications
Zongmei Wu ... Han Moshage
Published: July 13, 2022 Explor Dig Dis. 2022;1:4–20
Open Access
Review
Helicobacter pylori and gastric cancer: a critical approach to who really needs eradication
Elias Kouroumalis ... Argyro Voumvouraki
Published: April 16, 2024 Explor Dig Dis. 2024;3:107–142
This article belongs to the special issue Helicobacter Pylori and Infection: Genomics, Diagnosis, Pathogenesis, Antibiotic Resistance, Microbiota, Cancer, Prevention and Therapeutics
Open Access
Review
The multiple mechanisms and modes of cell death after acetaminophen overdose
Hartmut Jaeschke, Anup Ramachandran
Published: April 07, 2025 Explor Dig Dis. 2025;4:100569
Open Access
Review
Drug-induced cholestasis: causative agents and challenges in diagnosis and management
Jose M. Pinazo-Bandera ... Miren García-Cortés
Published: September 18, 2023 Explor Dig Dis. 2023;2:202–222
This article belongs to the special issue CHOLESTASIS
Open Access
Review
Helicobacter pylori infection and metabolic syndrome
Natalia V. Baryshnikova ... Alexander N. Suvorov
Published: September 10, 2024 Explor Dig Dis. 2024;3:414–427
This article belongs to the special issue Helicobacter Pylori and Infection: Genomics, Diagnosis, Pathogenesis, Antibiotic Resistance, Microbiota, Cancer, Prevention and Therapeutics
Open Access
Review
Zebrafish as a model for drug induced liver injury: state of the art and beyond
Gulcin Cakan-Akdogan ... Ozlen Konu
Published: April 26, 2023 Explor Dig Dis. 2023;2:44–55
This article belongs to the special issue Drug-induced Liver Injury: From Bench to Clinical Application
Open Access
Review
Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review
Miren García-Cortés ... Alberto García-García
Published: December 27, 2023 Explor Dig Dis 2023;2:318–336
This article belongs to the special issue Drug-induced Liver Injury: From Bench to Clinical Application
Open Access
Perspective
The intermicrovillar adhesion complex in gut barrier function and inflammation
Bernadette Mödl ... Robert Eferl
Published: October 11, 2022 Explor Dig Dis. 2022;1:72–79
Open Access
Review
Role of cholesterol homeostasis in MASH-driven hepatocellular carcinoma: not just a neutral fat
Vicent Ribas
Published: June 14, 2024 Explor Dig Dis. 2024;3:203–225
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Review
Metabolic dysfunction-associated steatotic liver disease (MASLD): emerging insights into gut microbiota interactions and therapeutic perspectives
Wenchu Qian ... Haifang Li
Published: June 30, 2025 Explor Dig Dis. 2025;4:100579
This article belongs to the special issue The Role of Gut Microbiota in the Pathogenesis and Management of Metabolic-Associated Steatotic Liver Disease (MASLD)
Open Access
Review
Etiopathogenesis and pathophysiology of cholestasis
Maitane Asensio ... Jose J. G. Marin
Published: October 31, 2022 Explor Dig Dis. 2022;1:97–117
This article belongs to the special issue CHOLESTASIS
Open Access
Review
Bile as a liquid biopsy matrix: potential applications and limitations
Maria Arechederra ... Carmen Berasain
Published: February 04, 2024 Explor Dig Dis. 2024;3:5–21
Open Access
Review
MASLD vs. MAFLD. A narrative review
Amedeo Lonardo ... Mohammed Eslam
Published: August 14, 2025 Explor Dig Dis. 2025;4:100586
Open Access
Review
Tumor immune microenvironment modulation by cholesterol in hepatocellular carcinoma
Alejandro Escobedo-Calvario ... María Concepción Gutiérrez-Ruíz
Published: July 29, 2022 Explor Dig Dis. 2022;1:21–39
Open Access
Review
Fructose, a trigger of metabolic diseases?—a narrative review
Anja Baumann ... Ina Bergheim
Published: August 29, 2022 Explor Dig Dis. 2022;1:51–71
Open Access
Review
Alcohol-related liver disease: also a question of what you drink?
Finn Jung ... Ina Bergheim
Published: June 30, 2023 Explor Dig Dis. 2023;2:118–132
PreviousJournal Information